These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2301006

  • 1. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE, Baldwin WM, Sanfilippo F.
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [Abstract] [Full Text] [Related]

  • 2. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B, Baldwin WM, Sanfilippo F.
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [Abstract] [Full Text] [Related]

  • 3. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM, Rhoton K, Sanfilippo F.
    Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
    [Abstract] [Full Text] [Related]

  • 4. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B, Baldwin WM, Howell DN, Sanfilippo F.
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [Abstract] [Full Text] [Related]

  • 5. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW, Baldwin WM, Sanfilippo F.
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [Abstract] [Full Text] [Related]

  • 6. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P, Coffman TM, Howell DN, Straznickas J, Scroggs MW, Baldwin WM, Klotman PE, Sanfilippo F.
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [Abstract] [Full Text] [Related]

  • 7. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
    Wray DW, Baldwin WM, Sanfilippo F.
    Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
    [Abstract] [Full Text] [Related]

  • 8. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B, Baldwin WM, Howell DN, Sanfilippo F.
    Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
    [Abstract] [Full Text] [Related]

  • 9. The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses.
    Wasowska B, Howell DN, Baldwin WM, Sanfilippo F.
    Transplantation; 1992 Jul; 54(1):136-42. PubMed ID: 1631922
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P, Fuller J, Sanfilippo F.
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [Abstract] [Full Text] [Related]

  • 11. The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance.
    Koshiba T, Van Damme B, Ji P, Sefrioui H, Rutgeerts O, Waer M, Pirenne J.
    Transpl Int; 2003 Jun; 16(6):383-90. PubMed ID: 12819868
    [Abstract] [Full Text] [Related]

  • 12. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
    Yang CP, Shittu E, McManus B, Wood PJ, Bell EB.
    Transplantation; 1998 Sep 15; 66(5):639-45. PubMed ID: 9753346
    [Abstract] [Full Text] [Related]

  • 13. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
    Mhoyan A, Cramer DV, Baquerizo A, Shirwan H.
    Transplantation; 1997 Dec 27; 64(12):1665-70. PubMed ID: 9422399
    [Abstract] [Full Text] [Related]

  • 14. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
    Yamamoto S, Ito T, Nakata S, Nozaki S, Uchikoshi F, Shirakura R, Kamiike W, Miyata M, Matsuda H.
    Transplantation; 1994 Apr 27; 57(8):1217-22. PubMed ID: 7909966
    [Abstract] [Full Text] [Related]

  • 15. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP, Shittu E, Bell EB.
    J Immunol; 2000 Mar 01; 164(5):2427-32. PubMed ID: 10679079
    [Abstract] [Full Text] [Related]

  • 16. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z, Jakobs FM, Pfaff-Amesse T, Sanfilippo F, Baldwin WM.
    J Heart Lung Transplant; 1998 May 01; 17(5):470-8. PubMed ID: 9628565
    [Abstract] [Full Text] [Related]

  • 17. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB, Baldwin WM, Ibrahim S, Sanfilippo F.
    Transplantation; 1995 Jan 27; 59(2):288-93. PubMed ID: 7839453
    [Abstract] [Full Text] [Related]

  • 18. A rat model of pregnancy-induced sensitization to transplants.
    Qian Z, Liu J, Fox-Talbot K, Wasowska BA, Baldwin WM.
    Transplant Proc; 2005 Jan 27; 37(1):96-7. PubMed ID: 15808559
    [Abstract] [Full Text] [Related]

  • 19. Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
    Singer JS, Mhoyan A, Fishbein MC, Shen XD, Gao F, Zhao D, Coito AJ, Reemtsen BL, Amersi F, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM.
    Transplantation; 2001 Oct 27; 72(8):1408-16. PubMed ID: 11685113
    [Abstract] [Full Text] [Related]

  • 20. Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation.
    Koshiba T, Kitade H, Waer M, Mathieu C, Van Damme B, Pirenne J.
    Transplant Proc; 2003 Dec 27; 35(8):3153-5. PubMed ID: 14698001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.